SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001920179-22-000001
Filing Date
2022-04-27
Accepted
2022-04-27 16:32:53
Documents
1
Period of Report
2022-02-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3101
  Complete submission text file 0001920179-22-000001.txt   4833
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Issuer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 42 SHAD THAMES LONDON X0 SE1 2YD
Business Address 42 SHAD THAMES LONDON X0 SE1 2YD 0044(0)2073979625
Renaissance Capital Partners Ltd (Reporting) CIK: 0001920179 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-41231 | Film No.: 22860193